Senseonics Holdings Inc
NASDAQ:SENS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Senseonics Holdings Inc
NASDAQ:SENS
|
US |
|
R
|
Reckitt Benckiser Group PLC
F:3RBB
|
UK |
|
MAP Aktif Adiperkasa Tbk PT
IDX:MAPA
|
ID |
|
Bank Mandiri (Persero) Tbk PT
IDX:BMRI
|
ID |
|
M
|
Matrix Concepts Holdings Bhd
KLSE:MATRIX
|
MY |
|
Marubeni Corp
F:MAR0
|
JP |
|
N
|
Neurocrine Biosciences Inc
XMUN:NB3
|
US |
|
Five Star Bancorp
F:4F6
|
US |
|
Thermax Limited
NSE:THERMAX
|
IN |
|
Creo Medical Group PLC
F:1RC
|
UK |
|
Schroders PLC
LSE:SDR
|
UK |
|
Lipocine Inc
NASDAQ:LPCN
|
US |
|
P
|
Pakuwon Jati Tbk PT
IDX:PWON
|
ID |
|
Brookfield Renewable Corp
NYSE:BEPC
|
US |
|
K
|
Kirkland's Inc
F:KI2
|
US |
|
Cineplex Inc
TSX:CGX
|
CA |
Wall St Price Targets
SENS Price Targets Summary
Senseonics Holdings Inc
According to Wall Street analysts, the average 1-year price target for SENS is 17 USD with a low forecast of 8.08 USD and a high forecast of 32.55 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SENS's stock price target?
Price Target
17
USD
According to Wall Street analysts, the average 1-year price target for SENS is 17 USD with a low forecast of 8.08 USD and a high forecast of 32.55 USD.
What is the Revenue forecast for Senseonics Holdings Inc?
Projected CAGR
41%
Over the last 9 years, the compound annual growth rate for Revenue has been 68%. The projected CAGR for the next 8 years is 41%.